SCHEMBL30155087

SCHEMBL30155087

c1ccc(-c2nc(-c3ccccc3)nc(-c3cc(-c4ccccn4)cc(-c4cc5ccccc5c5ccccc45)c3)n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.47
HSD17B10 Q99714 3/20 0.42
MAPK1 P28482 2/20 0.42
TSHR P16473 2/20 0.42
KDM4E B2RXH2 6/20 0.42
TDP1 Q9NUW8 1/20 0.42
SMN1; SMN2 Q16637 8/20 0.41
NPC1 O15118 5/20 0.41
RAB9A P51151 5/20 0.41
METAP1 P53582 1/20 0.41
ADORA3 P0DMS8 3/20 0.40
LMNA P02545 6/20 0.40
HPGD P15428 5/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
DHODH Q02127 1/20 0.39
TP53 P04637 3/20 0.39
PKM P14618 2/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17932322 1.00 CYP11B1 (0.47) CYP11B1HSD17B10MAPK1TSHRKDM4E
SCHEMBL9958274 0.93 CYP11B1 (0.43) CYP11B1HSD17B10MAPK1TSHRKDM4E
SCHEMBL9958605 0.93 CYP11B1 (0.43) CYP11B1HSD17B10MAPK1TSHRKDM4E
SCHEMBL17932406 0.93 CYP11B1 (0.43) CYP11B1HSD17B10MAPK1TSHRKDM4E
SCHEMBL17932341 0.93 MAPK1 (0.47) CYP11B1HSD17B10MAPK1TSHRKDM4E
SCHEMBL17932360 0.93 CYP11B1 (0.44) CYP11B1HSD17B10MAPK1TSHRKDM4E
SCHEMBL9956912 0.92 SMN1; SMN2 (0.45) CYP11B1HSD17B10MAPK1TSHRKDM4E
SCHEMBL24470221 0.92 KDM4E (0.47) CYP11B1HSD17B10MAPK1TSHRKDM4E
SCHEMBL27255765 0.89 TSHR (0.46) CYP11B1HSD17B10MAPK1TSHRKDM4E
SCHEMBL9960757 0.89 CYP11B1 (0.42) CYP11B1HSD17B10MAPK1TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12563963-B2 Electron injection layer for an organic light-emitting diode (OLED) NOVALED GMBH (DE) 2026-02-24 US disclosed
US-12161044-B2 Electron transport layer comprising a matrix compound mixture for an organic light-emitting diode (OLED) NOVALED GMBH (DE) 2024-12-03 US disclosed
CN-116171059-A Organic light emitting diode comprising organic semiconductor layer 诺瓦尔德股份有限公司 2023-05-26 CN disclosed
US-11594687-B2 Organic electroluminescent device NOVALED GMBH (DE) 2023-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12563963-B2 Electron injection layer for an organic light-emitting diode (OLED) ICOSLG, OXA1L, OSBP2 CYP11B1 215/4885HSD17B10 386/4885MAPK1 412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.